Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #7363 on Humanigen Inc (HGENQ)
fireopal
09/19/17 6:48 PM
#7364 RE: cowtown jay #7363
From Condor over at bankruptcy reviewed - recent 8K "...As a result of FDA’s actions and with the information currently available, Humanigen, Inc. no longer expects to be eligible to receive a PRV with its own benznidazole candidate for the treatment of Chagas disease. Accordingly, Humanigen is assessing its options in respect of that development program and the company’s monoclonal antibodies, lenzilumab and ifabotuzumab….” Condor here "All of the above means that Humanigen is highly likely to be approved as a benznidazole supplier, in the US — and reasonably soon. The question is whether that will be worth anything, since it will be second to market..." https://kalobiosbankruptcyreviewed.wordpress.com/